chronically
reserpinized
rat
possible
model
cystic
fibrosis
vi
synergistic
effects
isoproterenol
ca
protein
submaxillary
gland
elevated
calcium
protein
concentration
consistent
abnormality
submaxillary
saliva
patients
cystic
fibrosis
cf
experimental
animal
models
developed
chronic
administration
either
isoproterenol
ipr
reserpine
possibility
effects
two
drugs
may
additive
investigated
assessing
combined
effects
glandular
salivary
c
protein
rat
submaxillary
gland
individually
effects
also
assessed
relation
dose
used
results
indicate
treatment
days
mg
kg
daily
dose
reserpine
caused
respectively
increase
glandular
ca
increase
glandular
protein
treatment
days
mg
kg
daily
dose
isoproterenol
caused
increase
gland
ca
increase
gland
protein
treatment
mg
rat
daily
dose
drug
caused
increases
gland
ca
protein
experiments
involving
combination
two
drugs
isoproterenol
administered
mg
kg
daily
dose
days
reserpine
mg
kg
daily
dose
days
treatment
schedule
procedure
resulted
increase
gland
ca
increase
gland
protein
b
marked
accumulation
granular
basophilic
material
acinar
cells
development
intraductal
precipitates
c
secretion
turbid
saliva
high
ca
protein
concentrations
secretory
dose
isoproterenol
type
stimulation
also
reduced
gland
ca
protein
contents
produced
vacuolization
acinar
cells
secretion
saliva
elevated
ca
protein
response
pilocarpine
elevated
concentrations
however
one
fifth
obtained
isoproterenol
stimulation
e
secretion
smaller
volume
saliva
types
stimulation
findings
indicate
ipr
reserpine
dose
related
significant
effect
submaxillary
gland
ca
protein
individual
effects
synergistic
implications
synergism
physiologic
state
submaxillary
gland
secretory
abnormality
cystic
fibrosis
discussed
